FDA Valsartan Recall – Here’s What You Need To Know

Aug 15, 2018
by The Atkins & Markoff Team

FDA Valsartan Recall – Here’s What You Need To Know

Recall of Valsartan by the FDA

Some Blood Pressure Meds Are Being Recalled by the FDA — Here’s What to Know

The U.S. Food and Drug Administration – FDA – has been notifying health care professionals and patients of a recall of several pharmaceutical drugs that contain the active ingredient – Valsartan.

Valsartan is used to treat high blood pressure and also heart failure.

NDMA is the carcinogen that increases the risk of cancer in humans.

The recall is due to the fact, that they have found an impurity in the recalled products  – N-nitrosodimethylamine or NDMA – which is classified as a probable human carcinogen.

This NDMA chemical carcinogen could increase the risk of cancer in humans.

FDA is testing samples of Valsartan and found that some of the product contained unacceptable levels of NDMA, and are found to not be safe for use.

The FDA is working with drug manufactures to ensure that future Valsartan active pharmaceutical ingredients (API’s) are not at risk of the toxic NDMA formation.

The FDA has updated the list of valsartan products under recall so that patients can research and see if they are at risk.

If you’ve been diagnosed with one of these cancers:

– Liver cancer

– Kidney cancer

– Colorectal cancer

– Stomach cancer

If you have been diagnosed with cancer and have been taking Valsartan, please contact the law office of Atkins and Markoff immediately at 405-607-8757.